Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD

FDA APPROVAL OF MR-CONDITIONAL LABELING FOR THE ELLIPSE™ ICD FAMILY ADDS ANOTHER PATIENT-CENTRIC BENEFIT TO A DEVICE DESIGNED TO OPTIMIZE THE TREATMENT OF ABNORMALLY FAST HEART RHYTHMS ABBOTT PARK, Ill., Sept. 22, 2017 -- (Healthcare Sales & Marketing N... Devices, Cardiology, FDA Abbott, Ellipse ICD, implantable cardioverter defibrillator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news